Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia-Reference-Cited by-同舟云学术

Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia

Published:2014-04-10 Issue:8 Volume:140 Page:1367-1381
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Pfirrmann Markus, ,Saussele Susanne,Hochhaus Andreas,Reiter Andreas,Berger Ute,Hossfeld Dieter K.,Nerl Christoph,Scheid Christof,Spiekermann Karsten,Mayer Jiri,Hellmann Andrzej,Lechner Klaus,Falge Christiane,Sayer Herbert G.,Bunjes Donald,Ganser Arnold,Beelen Dietrich W.,Baldomero Helen,Schanz Urs,Heimpel Hermann,Kolb Hans-Jochem,Hasford Joerg,Gratwohl Alois,Hehlmann Rüdiger

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-014-1662-y.pdf

Reference25 articles.

1. Altman DG, Lausen B, Sauerbrei W, Schumacher M (1994) Dangers of using “optimal” cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86(11):829–835. doi: 10.1093/jnci/86.11.829

2. Archimbaud E, Thomas X, Michallet M, Jaubert J, Troncy J, Guyotat D, Fiere D (1994) Prospective genetically randomized comparison between intensive postinduction chemotherapy and bone marrow transplantation in adults with newly diagnosed acute myeloid leukemia. J Clin Oncol 12(2):262–267

3. Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF, Cervantes F, Clark RE, Cortes JE, Guilhot F, Hjorth-Hansen H, Hughes TP, Kantarjian HM, Kim D-W, Larson RA, Lipton JH, Mahon F-X, Martinelli G, Mayer J, Müller MC, Niederwieser D, Pane F, Radich JP, Rousselot P, Saglio G, Saußele S, Schiffer C, Silver R, Simonsson B, Steegmann J-L, Goldman JM, Hehlmann R (2013) European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood 122(6):872–884. doi: 10.1182/blood-2013-05-501569

4. Collett D (1994) Modelling survival data in medical research. Chapman & Hall, London

5. Corbiere F, Joly P (2007) A SAS macro for parametric and semiparametric mixture cure models. Comput Methods Progr Biomed 85(2):173–180. doi: 10.1016/j.cmpb.2006.10.008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic stem cell transplantation in chronic myeloid leukemia patients: Single center experience;World Journal of Hematology;2017

2. De Novo Design of New Inhibitor of Mutated Tyrosine-Kinase for the Myeloid Leukemia Treatment;Current Pharmaceutical Design;2016-11-09

3. The Role of Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia;Hematologic Malignancies;2016

4. Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment;Leukemia;2015-10-14

5. Transplant to treatment-free remission: the evolving view of ‘cure’ in chronic myeloid leukemia;Expert Review of Hematology;2015-09-12